As per GAVI (2022) it is estimated that Typhoid accounts for an estimated 11 to 21 million cases of febrile illness and ...

ZyVac TCV is designed for active immunization against Salmonella typhi infection in individuals aged 6 months to 65 years.

Zydus Lifesciences Ltd has received in-principle approval from the WHO for its Typhoid Vi conjugate vaccine, ZyVac TCV.

Zydus Lifesciences Ltd has received approval from the WHO for its Typhoid conjugate vaccine, ZyVac TCV, to be procured by United Nations agencies. Developed in Ahmedabad, it targets ages 6 months to ...

Approved in India as Oxemia for anemia, desidustat stimulates erythropoietin, a signaling molecule secreted in response to ...

From what is understood, as a part of the collaboration, Kapoor took to his social media handle to promote a healthy ...

Mumbai: Zydus Wellness' Sugar Free, a sweetener brand, has entered the packaged foods segment with Sugar Free D’lite cookies.

Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture ...

ICMR partners with Zydus Lifesciences for Desidustat phase-2 trials in sickle cell disease patients, aiming for innovative ...

Through the new addition, the brand aims to offer consumers with alternatives that do not contain any added sugar while ...

Zydus Lifesciences's Typhoid Vi conjugate vaccine, ZyVac TCV, has received WHO prequalification, making it eligible for UN ...